Direct Genomics Biotechnology Company
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $35M
Investors
- 2
About Direct Genomics Biotechnology Company
Based in Shenzhen, China and established in 2012, Direct Genomics Biotechnology Company focuses on providing genetic test services includes non-invasive prenatal testing, preimplantation genetic screening, cancer molecular diagnosis, pathogenic microorganism examination, pre-symptomatic genetic tests and so on.
Who invested in Direct Genomics Biotechnology Company
2 investors across 1 round
See all investors in Direct Genomics Biotechnology Company
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 19, 2018
Amount
$35M
Investors
Questions about Direct Genomics Biotechnology Company
Who invested in Direct Genomics Biotechnology Company?
Direct Genomics Biotechnology Company has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Direct Genomics Biotechnology Company raised?
Direct Genomics Biotechnology Company has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Direct Genomics Biotechnology Company last raise money?
Direct Genomics Biotechnology Company's most recent round on record is a Series A, in Apr 2018.
What does Direct Genomics Biotechnology Company do?
Based in Shenzhen, China and established in 2012, Direct Genomics Biotechnology Company focuses on providing genetic test services includes non-invasive prenatal testing, preimplantation genetic screening, cancer molecular diagnosis, pathogenic microorganism examination, pre-symptomatic genetic tests and so on.
Where is Direct Genomics Biotechnology Company headquartered?
Direct Genomics Biotechnology Company is headquartered in Shenzhen, China.
Which VCs invest in companies like Direct Genomics Biotechnology Company?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Direct Genomics Biotechnology Company's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Direct Genomics Biotechnology Company? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.